Literature DB >> 11283059

Single rapid real-time monitored isothermal RNA amplification assay for quantification of human immunodeficiency virus type 1 isolates from groups M, N, and O.

M P de Baar1, M W van Dooren, E de Rooij, M Bakker, B van Gemen, J Goudsmit, A de Ronde.   

Abstract

Because human immunodeficiency virus type 1 (HIV-1) subtypes and circulating recombinant forms (CRFs) are spreading rapidly worldwide and are becoming less confined to a geographical area, RNA assays that can detect and quantify all HIV-1 isolates reliably are in demand. We have developed a fast, real-time monitored RNA assay based on an isothermal nucleic acid sequence-based amplification technology that amplifies a part of the long terminal repeat region of the HIV-1 genome. Real-time detection was possible due to the addition of molecular beacons to the amplification reaction that was monitored in a fluorimeter with a thermostat. The lower level of detection of the assay was 10 HIV-1 RNA molecules per reaction, and the lower level of quantification was 100 copies of HIV-1 RNA with a dynamic range of linear quantification between 10(2) and 10(7) RNA molecules. All HIV-1 groups, subtypes, and CRFs could be detected and quantified with equal efficiency, including the group N isolate YBF30 and the group O isolate ANT70. To test the clinical utility of the assay, a series of 62 serum samples containing viruses that encompassed subtypes A through G and CRFs AE and AG of HIV-1 group M were analyzed, and these results were compared to the results of a commercially available assay. This comparison showed that the quantification results correlated highly (R(2) = 0.735) for those subtypes that could be well quantified by both assays (subtypes B, C, D, and F), whereas improved quantification was obtained for subtypes A and G and CRFs AE and AG. A retrospective study with six individuals infected with either a subtype A, B, C, or D or an AG isolate of HIV-1 group M, who were treated with highly active antiretroviral therapy, revealed that the assay was well suited to the monitoring of therapy effects. In conclusion, the newly developed real-time monitored HIV-1 assay is a fast and sensitive assay with a large dynamic range of quantification and is suitable for quantification of most if not all subtypes and groups of HIV-1.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11283059      PMCID: PMC87942          DOI: 10.1128/JCM.39.4.1378-1384.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  32 in total

1.  Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo.

Authors:  M P de Baar; W Janssens; A de Ronde; K Fransen; R Colebunders; L Kestens; G van der Groen; J Goudsmit
Journal:  AIDS Res Hum Retroviruses       Date:  2000-09-20       Impact factor: 2.205

2.  Rapid and simple method for purification of nucleic acids.

Authors:  R Boom; C J Sol; M M Salimans; C L Jansen; P M Wertheim-van Dillen; J van der Noordaa
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

3.  Isothermal, in vitro amplification of nucleic acids by a multienzyme reaction modeled after retroviral replication.

Authors:  J C Guatelli; K M Whitfield; D Y Kwoh; K J Barringer; D D Richman; T R Gingeras
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

4.  Subtype-specific sequence variation of the HIV type 1 long terminal repeat and primer-binding site.

Authors:  M P De Baar; A De Ronde; B Berkhout; M Cornelissen; K H Van Der Horn; A M Van Der Schoot; F De Wolf; V V Lukashov; J Goudsmit
Journal:  AIDS Res Hum Retroviruses       Date:  2000-03-20       Impact factor: 2.205

5.  Qualitative and quantitative detection of HIV-1 RNA by nucleic acid sequence-based amplification.

Authors:  B van Gemen; T Kievits; P Nara; H G Huisman; S Jurriaans; J Goudsmit; P Lens
Journal:  AIDS       Date:  1993-11       Impact factor: 4.177

6.  The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course?

Authors:  S Jurriaans; B Van Gemen; G J Weverling; D Van Strijp; P Nara; R Coutinho; M Koot; H Schuitemaker; J Goudsmit
Journal:  Virology       Date:  1994-10       Impact factor: 3.616

7.  Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group.

Authors:  P M Garcia; L A Kalish; J Pitt; H Minkoff; T C Quinn; S K Burchett; J Kornegay; B Jackson; J Moye; C Hanson; C Zorrilla; J F Lew
Journal:  N Engl J Med       Date:  1999-08-05       Impact factor: 91.245

8.  Use of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 to assess the performance of viral RNA quantitation tests.

Authors:  L L Jagodzinski; D L Wiggins; J L McManis; S Emery; J Overbaugh; M Robb; S Bodrug; N L Michael
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

9.  Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus.

Authors:  S P Layne; M J Merges; M Dembo; J L Spouge; S R Conley; J P Moore; J L Raina; H Renz; H R Gelderblom; P L Nara
Journal:  Virology       Date:  1992-08       Impact factor: 3.616

10.  Kinetic PCR analysis: real-time monitoring of DNA amplification reactions.

Authors:  R Higuchi; C Fockler; G Dollinger; R Watson
Journal:  Biotechnology (N Y)       Date:  1993-09
View more
  21 in total

Review 1.  Characteristics and applications of nucleic acid sequence-based amplification (NASBA).

Authors:  Birgit Deiman; Pierre van Aarle; Peter Sillekens
Journal:  Mol Biotechnol       Date:  2002-02       Impact factor: 2.695

2.  Development of conventional and real-time nucleic acid sequence-based amplification assays for detection of Chlamydophila pneumoniae in respiratory specimens.

Authors:  K Loens; T Beck; H Goossens; D Ursi; M Overdijk; P Sillekens; M Ieven
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

3.  One-tube real-time isothermal amplification assay to identify and distinguish human immunodeficiency virus type 1 subtypes A, B, and C and circulating recombinant forms AE and AG.

Authors:  M P de Baar; E C Timmermans; M Bakker; E de Rooij; B van Gemen; J Goudsmit
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

4.  Single real-time reverse transcription-PCR assay for detection and quantification of genetically diverse HIV-1, SIVcpz, and SIVgor strains.

Authors:  Lucie Etienne; Sabrina Eymard-Duvernay; Avelin Aghokeng; Christelle Butel; Marjorie Monleau; Martine Peeters
Journal:  J Clin Microbiol       Date:  2012-12-19       Impact factor: 5.948

5.  Overseas processing of dried blood spots for timely diagnosis of HIV in Haitian infants.

Authors:  Louise C Ivers; Mary Catherine Smith Fawzi; Julie Mann; Jean-Gregory Jerome; Maxi Raymonville; Joia S Mukherjee
Journal:  Rev Panam Salud Publica       Date:  2008-11

6.  SD-chip enabled quantitative detection of HIV RNA using digital nucleic acid sequence-based amplification (dNASBA).

Authors:  Jiasi Wang; Jason E Kreutz; Alison M Thompson; Yuling Qin; Allison M Sheen; Jingang Wang; Li Wu; Shihan Xu; Ming Chang; Dana N Raugi; Robert A Smith; Geoffrey S Gottlieb; Daniel T Chiu
Journal:  Lab Chip       Date:  2018-11-06       Impact factor: 6.799

7.  Evaluation of the clinical sensitivities of three viral load assays with plasma samples from a pediatric population predominantly infected with human immunodeficiency virus type 1 subtype G and BG recombinant forms.

Authors:  Rute Antunes; Sofia Figueiredo; Inês Bártolo; Manuel Pinheiro; Lino Rosado; Isabel Soares; Helena Lourenço; Nuno Taveira
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

8.  Lack of longitudinal intrapatient correlation between p24 antigenemia and levels of human immunodeficiency virus (HIV) type 1 RNA in patients with chronic hiv infection during structured treatment interruptions.

Authors:  Julia G Prado; Ayumi Shintani; Margarita Bofill; Bonaventura Clotet; Lidia Ruiz; Javier Martinez-Picado
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

9.  Evaluation of automated sample preparation and quantitative PCR LCx assay for determination of human immunodeficiency virus type 1 RNA.

Authors:  Zsofia Muller; Evelyn Stelzl; Michael Bozic; Josef Haas; Egon Marth; Harald H Kessler
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

10.  Development of a nucleic acid sequence-based amplification assay that uses gag-based molecular beacons to distinguish between human immunodeficiency virus type 1 subtype C and C' infections in Ethiopia.

Authors:  Workenesh Ayele; Georgios Pollakis; Almaz Abebe; Bitew Fisseha; Belete Tegbaru; Girma Tesfaye; Yohannes Mengistu; Dawit Wolday; Bob van Gemen; Jaap Goudsmit; Wendelien Dorigo-Zetsma; Michel P de Baar
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.